| Laura Ridings, MS, CCC-SLP | |
|
1493 Cambridge St, Cambridge, MA 02139-1047 | |
| (617) 591-4601 | |
| Not Available |
| Full Name | Laura Ridings |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1493 Cambridge St, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376303065 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 78388 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura Ridings, MS, CCC-SLP 320 D St Unit 434, South Boston, MA 02127-1283 Ph: (522) 030-7549 | Laura Ridings, MS, CCC-SLP 1493 Cambridge St, Cambridge, MA 02139-1047 Ph: (617) 591-4601 |
News Archive
For couples hoping for a baby via in vitro fertilization, chances have improved. A process that once took hours now takes minutes: Cornell University scientists have created a microfluidic device that quickly corrals strong and speedy sperm viable for fertilization.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and The Ohio State University Wexner Medical Center are conducting a new clinical trial to determine if an oral cancer drug called ibrutinib can also help patients with cancer or other immunocompromised conditions recover from COVID-19.
Nanosonics Limited (ASX: NAN) is pleased to announce it has been named the healthcare industry's Company of the Year for 2013.
Previous studies have also linked hypertension to severe coronavirus disease (COVID-19). Now, a new study by researchers at the University of East Anglia's Norwich Medical School has found that the risk of severe COVID-19 and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).
CorMatrix Cardiovascular, Inc., a medical device company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, today announced that the Company has been awarded $2.3 million in grants under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of their unique ECM technology.
› Verified 1 days ago
Rachel Toran Towbin, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-2422 | |
Ms. Susan Haley, M.S., CCC-SLP, ATP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 395 Broadway Apt R4c, Cambridge, MA 02139 Phone: 617-828-5355 | |
Mary Ellen D'agostino, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 33 1/2 Essex St, Cambridge, MA 02139 Phone: 203-506-8654 | |
Ashley Pratte, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-2300 | |
Dr. Jennifer Marie Thomson, PHD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 86 Wendell St Apt 3, Cambridge, MA 02138 Phone: 857-998-1786 | |
Creative Connections Pediatrics Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Charles St Apt 507, Cambridge, MA 02141 Phone: 617-468-8464 | |
Kathryn R Harlukowicz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 799 Concord Ave, Cambridge, MA 02138 Phone: 617-868-2200 |